Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic? - PubMed
. 2011 Oct;36(10):669-84.
- PMID: 22346300
- PMCID: PMC3278148
Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?
C Lee Ventola. P T. 2011 Oct.
No abstract available
Figures
Direct-to-consumer (DTC) advertising, 1998–2009. November 14, 2008. (Graph prepared by Pharma Marketing News.3)
Trends in FDA enforcement of direct-to-consumer drug advertising regulations, 1997–2006. (Data from the FDA’s Division of Drug Marketing, Advertising, and Communications.)
Similar articles
-
A decade of direct-to-consumer advertising of prescription drugs.
Donohue JM, Cevasco M, Rosenthal MB. Donohue JM, et al. N Engl J Med. 2007 Aug 16;357(7):673-81. doi: 10.1056/NEJMsa070502. N Engl J Med. 2007. PMID: 17699817
-
Promotion of prescription drugs to consumers.
Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Rosenthal MB, et al. N Engl J Med. 2002 Feb 14;346(7):498-505. doi: 10.1056/NEJMsa012075. N Engl J Med. 2002. PMID: 11844852
-
Direct-to-consumer drug marketing: public service or disservice?
Berger JT, Kark P, Rosner F, Packer S, Bennett AJ. Berger JT, et al. Mt Sinai J Med. 2001 May;68(3):197-202. Mt Sinai J Med. 2001. PMID: 11373692
-
Direct-to-consumer advertising of pharmaceuticals.
Gellad ZF, Lyles KW. Gellad ZF, et al. Am J Med. 2007 Jun;120(6):475-80. doi: 10.1016/j.amjmed.2006.09.030. Am J Med. 2007. PMID: 17524744 Free PMC article. Review.
-
Benefits and harms of direct to consumer advertising: a systematic review.
Gilbody S, Wilson P, Watt I. Gilbody S, et al. Qual Saf Health Care. 2005 Aug;14(4):246-50. doi: 10.1136/qshc.2004.012781. Qual Saf Health Care. 2005. PMID: 16076787 Free PMC article. Review.
Cited by
-
Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder.
Zaitsu M, Yoo BK, Tomio J, Nakamura F, Toyokawa S, Kobayashi Y. Zaitsu M, et al. BMC Health Serv Res. 2018 May 3;18(1):325. doi: 10.1186/s12913-018-3147-1. BMC Health Serv Res. 2018. PMID: 29724205 Free PMC article.
-
Schaper M, Schicktanz S. Schaper M, et al. BMC Med Ethics. 2018 Jun 5;19(1):56. doi: 10.1186/s12910-018-0292-3. BMC Med Ethics. 2018. PMID: 29871685 Free PMC article.
-
Drug promotion practices: A review.
Jacob NT. Jacob NT. Br J Clin Pharmacol. 2018 Aug;84(8):1659-1667. doi: 10.1111/bcp.13513. Epub 2018 Feb 20. Br J Clin Pharmacol. 2018. PMID: 29349812 Free PMC article. Review.
-
Pharmaceutical policies: effects of policies regulating drug marketing.
Fulone I, Cadogan C, Barberato-Filho S, Bergamaschi CC, Mazzei LG, Lopes LP, Silva MT, Lopes LC. Fulone I, et al. Cochrane Database Syst Rev. 2023 Jun 8;6(6):CD013780. doi: 10.1002/14651858.CD013780.pub2. Cochrane Database Syst Rev. 2023. PMID: 37288951 Free PMC article. Review.
-
Suryanarayanan A. Suryanarayanan A. Pharmacy (Basel). 2021 Sep 2;9(3):149. doi: 10.3390/pharmacy9030149. Pharmacy (Basel). 2021. PMID: 34564556 Free PMC article.
References
-
- Kuehn BM. FDA weighs limits for online ads. JAMA. 2010;303(4):311–313. - PubMed
-
- DTC marketing mix: Radio and outdoor ad spending soars, Internet not so much. Pharma Marketing. Available at: http://pharmamkting.blogspot.com/2010/06/dtc-marketing-mix-radio-outdoor.... Accessed July 28, 2011.
-
- Abel GA, Penson RT, Joffe S, et al. Direct-to-consumer advertising in oncology. Oncologist. 2006;11(2):217–226. - PubMed
-
- Connors AL. Big bad pharma: An ethical analysis of physician-directed and consumer-directed marketing tactics. Albany Law Rev. 2009;73(1):243–282. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources